Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials

Dengue is prevalent in the Asia-Pacific region. Participants of two immunogenicity and safety phase II studies conducted in Singapore and Vietnam (NCT0088089 and NCT00875524, respectively) were followed for up to four years after third vaccine dose of a recombinant, live, attenuated, tetravalent den...

Descripción completa

Detalles Bibliográficos
Autores principales: Tran, Ngoc Huu, Chansinghakul, Danaya, Chong, Chia Yin, Low, Chian Yong, Shek, Lynette P., Luong, Chan Quang, Fargo, Carina, Wartel, T. Anh, Sun, Sunny, Skipetrova, Anna, Bouckenooghe, Alain
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816352/
https://www.ncbi.nlm.nih.gov/pubmed/30724660
http://dx.doi.org/10.1080/21645515.2019.1578595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6816352/
https://www.ncbi.nlm.nih.gov/pubmed/30724660
http://dx.doi.org/10.1080/21645515.2019.1578595

Ejemplares similares